Ultrasound Guided Versus Land-mark Method for Spinal Anesthesia in Super Obesity Parturients
Comparison of Ultrasound and Anatomical Landmark Method in Spinal Anesthesia for Elective Cesarean Section in Super Obese Parturients With BMI ≥ 50 kg/m2. A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will investigate whether an ultrasound-assisted technique is better than a classical land-mark technique to facilitate spinal anesthesia in the sitting position in super obese pregnant women with BMI ≥ 50 who will undergo elective cesarean section. The primary objective of this study is the rate of successful dural puncture at the first attempt. It was assumed that ultrasound could facilitate neuraxial blockade in super obese (BMI ≥ 50 kg/m2), pregnant women, according to the Who classification, whose topographic anatomy is difficult.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2024
CompletedFirst Posted
Study publicly available on registry
May 13, 2024
CompletedStudy Start
First participant enrolled
May 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2025
CompletedFebruary 25, 2026
November 1, 2025
1.5 years
April 4, 2024
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The success rate of the first puncture
Success on a single-puncture attempt will be defined as reaching the subarachnoid space on the first insertion of the needle.
30 minute
Secondary Outcomes (12)
Number of skin punctures
30 minute
Number of needle pass
30 minute
The procedure duration time
30 minute
Time interval to determine needle insertion site
30 minute
Time taken for spinal injection
30 minute
- +7 more secondary outcomes
Study Arms (2)
Ultrasound method group
ACTIVE COMPARATORThe ultrasound-assisted technique will be used for spinal anesthesia performance.
Landmark method group
EXPERIMENTALLand-mark assisted technique will be used for spinal anesthesia performance.
Interventions
In the operating room, all of the patients will receive standard monitoring. Scans will be made in logiditunal parasagittal and transverse midline views with ultrasound. Needle entry sites in the L2-L3 and L3-L4 intervals will be determined as the intersection of the longiditunal and transverse lines. When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.
In the Landmark group, the injection site will be determined using the traditional method of palpating the posterior superior iliac spine.When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.
Eligibility Criteria
You may qualify if:
- Parturient who will receive selective cesarean delivery under spinal anesthesia
- ASA 3 scheduled for elective sections
- BMI≥50 kg/m2
- Normal singleton pregnancy
- weeks of gestation
You may not qualify if:
- Multiple gestations
- Emergency C-section
- Exist contraindications of spinal anesthesia
- Local anesthetics allergy
- BMI\<50 kg/m2
- History of lumbar spinal diseases and lumbar surgery
- Parturient refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karaman Training and Research Hospital
Karaman, 70200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşegül Bilge, MD
Karaman TRH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2024
First Posted
May 13, 2024
Study Start
May 16, 2024
Primary Completion
November 28, 2025
Study Completion
November 28, 2025
Last Updated
February 25, 2026
Record last verified: 2025-11